Pluri (PLUR) Accounts Payables (2011 - 2025)
Pluri (PLUR) posted quarterly Accounts Payables of $1.0 million for Q4 2025, down 8.57% year-over-year from $1.1 million in Q4 2024, and up 15.62% quarter-over-quarter from $877000.0 in Q3 2025.
Pluri (PLUR) Accounts Payables (2011 - 2025) Analysis & Trends
Pluri (PLUR) has reported Accounts Payables for 15 consecutive years, with $1.0 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Accounts Payables fell 8.57% year-over-year to $1.0 million; the TTM figure through Dec 2025 stood at $1.0 million (down 8.57% YoY), while the FY2025 annual figure was $1.3 million, up 37.86% from the prior year.
- Accounts Payables advanced to $1.0 million in Q4 2025 per PLUR's latest filing, from $877000.0 in the prior quarter.
- Across five years, Accounts Payables topped out at $2.6 million in Q4 2021 and bottomed at $877000.0 in Q3 2025.
- Historically, Accounts Payables has averaged $1.5 million across 5 years, with a median of $1.3 million in 2022.
- Annual changes were most pronounced in 2022 — Accounts Payables slumped 51.77% — and 2025, when it surged 37.86%.
- Pluri's Accounts Payables stood at $2.6 million in 2021, then tumbled by 51.77% to $1.3 million in 2022, then dropped by 12.17% to $1.1 million in 2023, then gained by 0.45% to $1.1 million in 2024, then retreated by 8.57% to $1.0 million in 2025.
- Business Quant data shows PLUR's Accounts Payables at $1.0 million in Q4 2025, $877000.0 in Q3 2025, and $1.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | Pluri | 16.21 Mn | 3.72 Mn | 86,000.00 | 1.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.01 Mn |
| Sep 30, 2025 | 877,000.00 |
| Jun 30, 2025 | 1.33 Mn |
| Mar 31, 2025 | 1.25 Mn |
| Dec 31, 2024 | 1.11 Mn |
| Sep 30, 2024 | 1.13 Mn |
| Jun 30, 2024 | 964,000.00 |
| Mar 31, 2024 | 1.03 Mn |
| Dec 31, 2023 | 1.10 Mn |
| Sep 30, 2023 | 973,000.00 |
| Jun 30, 2023 | 1.81 Mn |
| Mar 31, 2023 | 1.45 Mn |
| Dec 31, 2022 | 1.26 Mn |
| Sep 30, 2022 | 1.33 Mn |
| Jun 30, 2022 | 1.74 Mn |
| Mar 31, 2022 | 2.39 Mn |
| Dec 31, 2021 | 2.61 Mn |
| Sep 30, 2021 | 2.30 Mn |
| Jun 30, 2021 | 2.53 Mn |
| Mar 31, 2021 | 2.11 Mn |